Mary Mitchell O'Connor (Dún Laoghaire, Fine Gael) | Oireachtas source

It has to be novel, useful and it has to be non-obvious. The KDB is different to a patent so the systems are different. The research and development activity has to take place here. If the research and development activity takes place outside the country, it will not be recognised here for KDB. On the question of whether it is novel or non-obvious, where a company redesigns or adds something new to a machine it is already making and does that here in Ireland, it will quality if it is novel, non-obvious and useful. First, it will ask whether it qualifies and then the Revenue Commissioners will look at it. The IP has to be in Ireland. The new piece has to be here. It is not related to production. It is actually a question of what the new IP is, what is new about it, what is non-obvious and what is novel. I am sorry to keep repeating it, but that is what is stated in the Bill.